Related Experiment Video
Updated: Apr 3, 2026
Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
Published on: August 6, 2014
Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors
Niklas Klümper1, Isabella Syring1,2, Anne Offermann1
1Section for Prostate Cancer Research, Institute of Pathology, Center for Integrated Oncology Cologne/Bonn, University Hospital of Bonn, Bonn, Germany.
Background:
Testicular germ cell tumors (TGCT) are the most common cancer entities in young men with increasing incidence observed in the last decades. For therapeutic management it is important, that TGCT are divided into several histological subtypes. MED15 is part of the multiprotein Mediator complex which presents an integrative hub for transcriptional regulation and is known to be deregulated in several malignancies, such as prostate cancer and bladder cancer role, whereas the role of the Mediator complex in TGCT has not been investigated so far. Aim of the study was to investigate the implication of MED15 in TGCT development and its stratification into histological subtypes.
Methods:
Immunohistochemical staining (IHC) against Mediator complex subunit MED15 was conducted on a TGCT cohort containing tumor-free testis (n = 35), intratubular germ cell neoplasia unclassified (IGCNU, n = 14), seminomas (SEM, n = 107) and non-seminomatous germ cell tumors (NSGCT, n = 42), further subdivided into embryonic carcinomas (EC, n = 30), yolk sac tumors (YST, n = 5), chorionic carcinomas (CC, n = 5) and teratomas (TER, n = 2). Quantification of MED15 protein expression was performed through IHC followed by semi-quantitative image analysis using the Definiens software.
Results:
In tumor-free seminiferous tubules, MED15 protein expression was absent or only low expressed in spermatogonia. Interestingly, the precursor lesions IGCNU exhibited heterogeneous but partly very strong MED15 expression. SEM weakly express the Mediator complex subunit MED15, whereas NSGCT and especially EC show significantly enhanced expression compared to tumor-free testis.
Conclusions:
In conclusion, MED15 is differentially expressed in tumor-free testis and TGCT. While MED15 is absent or low in tumor-free testis and SEM, NSGCT highly express MED15, hinting at the diagnostic potential of this marker to distinguish between SEM and NSGCT. Further, the precursor lesion IGCNU showed increased nuclear MED15 expression in the preinvasive precursor cells, which may provide diagnostic value to distinguish between benign and pre-malignant testicular specimen, and may indicate a role for MED15 in carcinogenesis in TGCT.
Insights
MED15 protein is differentially expressed in testicular germ cell tumors (TGCT). This Mediator complex subunit is low in normal testis and seminomas but high in non-seminomas, suggesting diagnostic potential.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Testicular germ cell tumors (TGCT) are the most common cancer in young men, with increasing incidence.
- Histological subtyping is crucial for TGCT therapeutic management.
- The Mediator complex subunit MED15's role in TGCT is uninvestigated, despite its known deregulation in other cancers.
Purpose of the Study:
- To investigate the implication of MED15 in TGCT development.
- To analyze MED15 expression in different TGCT histological subtypes.
Main Methods:
- Immunohistochemical staining (IHC) for MED15 was performed on a cohort of TGCTs, including normal testis, intratubular germ cell neoplasia unclassified (IGCNU), seminomas (SEM), and non-seminomatous germ cell tumors (NSGCT).
- MED15 protein expression was quantified using semi-quantitative image analysis software.
Main Results:
- MED15 expression was absent or low in normal seminiferous tubules and seminomas.
- Intratubular germ cell neoplasia unclassified (IGCNU) showed heterogeneous but sometimes strong MED15 expression.
- Non-seminomatous germ cell tumors (NSGCT), particularly embryonic carcinomas (EC), exhibited significantly enhanced MED15 expression compared to normal testis.
Conclusions:
- MED15 is differentially expressed across TGCT subtypes and normal testis.
- High MED15 expression in NSGCT suggests its potential as a diagnostic marker to differentiate from SEM.
- Increased MED15 in IGCNU may indicate a role in TGCT carcinogenesis and aid in distinguishing pre-malignant lesions.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
08:30Isolate Cell-Type-Specific RNAs from Snap-Frozen Heterogeneous Tissue Samples without Cell Sorting
Published on: December 8, 2021
